DeWolf creates new regulatory & compliance manager role

Jeffrey Devolve has been named regulatory & compliance manager for The DeWolf Companies. In the newly created role, Devolve will be responsible for planning, developing and directing all regulatory compliance programmes and overseeing all matters concerning the ISO 9001 and NACD Business Management System with a primary focus on implementing, communicating and measuring non-conformance solutions.

Devolve previously served in this capacity at EC Pigments USA and has held R&D chemical technician positions at both Cuming Corporation and Clariant Corporation.

You may also like

Ingredients

KODA acquires The DeWolf Companies

North American specialty chemicals distributor forms new KODA Care business unit
Ingredients

NYSCC Suppliers' Day – Garden State science

Although the 2011 NYSCC Suppliers’ Day (10-11 May) was a bigger and better affair than last year’s event, its focus on formulating remained the same. Julia Wray reports from New Jersey
Ingredients

The DeWolf Companies creates colour division

New division to grow business
Ingredients

FDA unable to determine safety of ‘forever chemicals’ in cosmetics

A lack of available data on the perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products has left the US Food and Drug Administration (FDA) unable to fully assess their risks
Ingredients

Syensqo’s Moerdijk plant receives ISCC PLUS mass-balance certification for bio-circular products

Certification enables the use of bio-circular raw materials to produce 100% natural, lower-carbon surfactants for laundry care brands
Ingredients

PromaCare NAA: supramolecular cocrystal technology for brightening and soothing

This crystal-driven design effectively improves the water solubility and formulation compatibility of azelaic acid, while enhancing the fat solubility and stability of niacinamide under over-acid conditions
Ingredients

dsm-firmenich welcomes FDA proposal to expand US sunscreen actives, paving the way for PARSOL Shield

This proposal marks a historic milestone as it follows the first-ever Tier 1 OTC Monograph Order Request (OMOR) to be submitted to FDA – by dsm-firmenich - to amend OTC Monograph M020 and permit PARSOL® Shield at concentrations up to 6%
Subscribe now